CDLX (Cardlytics) 3-Year ROIIC % : -22.72% (As of Dec. 2025)


CDLX Cardlytics Inc CDLX
34 GF Score
Price $4.40
GF Value $18.48
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Cardlytics 3-Year ROIIC %?

Cardlytics CDLX -1.68% 34 3-Year ROIIC % is -22.72 as of Dec. 2025. GuruFocus rates CDLX with a GF Score™ of 34/100 and a GF Value™ of $18.48 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 949 Media - Diversified companies, Cardlytics ranks worse than 74.08% on this metric.

3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year. Cardlytics's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was -22.72%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Cardlytics's 3-Year ROIIC % or its related term are showing as below:

CDLX's 3-Year ROIIC % is ranked worse than
74.08% of 949 companies
in the Media - Diversified industry
Industry Median: 1.56 vs CDLX: -22.72

Cardlytics  (NAS:CDLX) 3-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Cardlytics 3-Year ROIIC % Related Terms


Cardlytics 3-Year ROIIC % Historical Data

* Premium members only.

The historical data trend for Cardlytics's 3-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cardlytics 3-Year ROIIC % Chart

Cardlytics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
3-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.84 -23.02 -2.82 -3.33 -22.72

Cardlytics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
3-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -22.72 0.00

CDLX vs WIMI, ACCS, HAFG: 3-Year ROIIC % Comparison

For the Advertising Agencies subindustry, Cardlytics's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cardlytics 3-Year ROIIC % vs Media - Diversified Industry

For the Media - Diversified industry and Communication Services sector, Cardlytics's 3-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Cardlytics's 3-Year ROIIC % falls into.


CDLX
34GF Score
Cardlytics Inc CDLX
3-Year ROIIC % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cardlytics 3-Year ROIIC % Calculation

Cardlytics's 3-Year ROIIC % for the quarter that ended in Dec. 2025 is calculated as:

3-Year ROIIC %=3-Year Incremental Net Operating Profit After Taxes (NOPAT)**/3-Year Incremental Invested Capital**
=( -45.705 (Dec. 2025) - -135.1178322 (Dec. 2022) )/( 168.833 (Dec. 2025) - 562.462 (Dec. 2022) )
=89.4128322/-393.629
=-22.72%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.

Frequently Asked Questions Learn more about 3-Year ROIIC % →
What does a 3-Year ROIIC % of -22.72 mean?
Cardlytics (CDLX) has a 3-Year ROIIC % of -22.72 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Cardlytics and its competitors. According to the industry distribution chart, Cardlytics ranks #703 out of 949 companies in the Media - Diversified industry, placing it in the top 74.1%.
Is Cardlytics' 3-Year ROIIC % too high?
Cardlytics' current 3-Year ROIIC % is -22.72. Based on the distribution chart, Cardlytics ranks #703 out of 949 companies in the Media - Diversified industry, which is below the industry midpoint. Overall, Cardlytics has a GF Score™ of 34/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Cardlytics' 3-Year ROIIC % compare to WIMI and ACCS?
According to the Media - Diversified industry distribution chart, Cardlytics ranks #703 out of 949 companies for 3-Year ROIIC %. This places Cardlytics in the lower half of its industry. The industry median 3-Year ROIIC % is 1.56. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Media - Diversified company?
The median 3-Year ROIIC % among Media - Diversified companies is 1.56, based on 949 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Cardlytics and its competitors. For the Media - Diversified industry, the median 3-Year ROIIC % is 1.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cardlytics's current 3-Year ROIIC % is -22.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cardlytics stock overvalued right now?
Based on GuruFocus' analysis, Cardlytics (CDLX) is currently considered Possible Value Trap. The stock's GF Value™ is $18.48, compared to a current price of $4.40 — trading 76.2% below its estimated fair value. The current 3-Year ROIIC % is -22.72. Cardlytics' overall GF Score™ is 34/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Cardlytics (CDLX), the current 3-Year ROIIC % is -22.72 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cardlytics (CDLX) Overvalued in 2026?

Based on GuruFocus' analysis, Cardlytics stock appears to be undervalued. The current stock price of $4.40 is trading 76.2% below its estimated GF Value™ of $18.48. GuruFocus considers Cardlytics to be Possible Value Trap.

Key valuation signals for CDLX:

  • 3-Year ROIIC %: -22.72
  • GF Value™: $18.48 vs. price of $4.40 (76.2% below fair value)
  • GF Score™: 34/100 with 4 warning signs

No single metric tells the full story. See the CDLX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cardlytics Business Description

Other Exchanges 0LEC:UKCYX0:Germany
Address 675 Ponce de Leon Avenue, NE, Suite 4100, Atlanta, GA, USA, 30308
Cardlytics Inc is a commerce media platform that is designed to make commerce smarter and rewarding for everyone. At the core of its commerce media platform is the financial media network that it runs within its partners' digital channels, which includes online and mobile applications (the Cardlytics platform). Additionally, it operates an identity resolution platform that utilizes point-of-sale (POS) data, including product-level purchase data, to enable marketers to perform analytics and targeted loyalty marketing and also measure the impact of their marketing (the Bridg platform). It operates in three segments: the Cardlytics platform in the U.S.; the Cardlytics platform in the U.K.; and the Bridg platform. The majority of the revenue is derived from the Cardlytics platform.
34GF Score

Get the complete analysis for CDLX

3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.40
Price
$18.48
GF Value